Records containing: Type 2 Diabetes Mellitus

This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.

• CLINICAL_TRIALS study record update · 2013-11-28
  The Role of GIP, GLP-1 and GLP-2 in Type 2 Diabetic Hyperglucagonemia
• CLINICAL_TRIALS study record update · 2013-11-28
  A 52-Week, Randomised, Double Blind, Active-Controlled, Multi-Centre Phase IIIb/IV Study to Evaluate the Efficacy and Tolerability of Saxagliptin Compared to Glimepiride in Elderly Patients With Type 2 Diabetes Mellitus Who Have Inadequate Glycaemic Control on Metformin Monotherapy
• CLINICAL_TRIALS study record update · 2013-11-27
  A Randomized, Open-label, Multiple Dosing, Three-way Crossover Clinical Trial to Investigate the Pharmacokinetic/Pharmacodynamic Drug-drug Interaction of DA-1229 5 mg and Metformin IR 1000 mg After Oral Administration in Healthy Male Volunteers
• CLINICAL_TRIALS study record update · 2013-11-27
  A Pilot Study of Self Management Using Application for Chronic Disease Care in Real siTuation (SMART) - DM
• CLINICAL_TRIALS study record update · 2013-11-25
  Targeting Inflammation in Type 2 Diabetes: Clinical Trial Using Salsalate
• Organize your saved records without ads with Plus.
• CLINICAL_TRIALS study record update · 2013-11-14
  Testosterone Therapy of Men With Type 2 Diabetes Mellitus (T2DM) - a Randomised, Doubleblinded and Placebocontrolled Trial of Men With Subnormal Testosterone Levels and T2DM.
• CLINICAL_TRIALS study record update · 2013-10-31
  Community Based Participatory Research With Immigrant Chinese With Type 2 Diabetes: Adapting and Testing Coping Skills Training.
• CLINICAL_TRIALS study record update · 2013-10-31
  A Randomized, Double-blind, Placebo-controlled Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, a Selective Glucagon-like Peptide (GLP) 1 Agonist, Following Subcutaneous Administration in Healthy Volunteers.
• CLINICAL_TRIALS study record update · 2013-10-28
  A Phase III Study of MP-513 in Combination With Thiazolidinedione in Japanese Patients With Type 2 Diabetes Mellitus
• CLINICAL_TRIALS study record update · 2013-10-17
  A Double Blind, Double Dummy, Randomised, Multi-centre Study to Assess the Tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy With Metformin in Muslim Patients With Type 2 Diabetes Fasting During Ramadan
• CLINICAL_TRIALS study record update · 2013-10-16
  Comparison of Metformin and Pioglitazone Effects on Serum YKL-40 Concentrations in Patients With Newly Diagnosed Type 2 Diabetes
• CLINICAL_TRIALS study record update · 2013-10-14
  A 24-week,Multi-centre,Int.,Double-blind,Rand.,Parallel-group,Plac.-Controlled,Phase III Study With a 78-week Ext.Per. to Evaluate the Effect of Dapagliflozin in Combination With Metformin on Body Weight in Subjects With Type2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Alone
• CLINICAL_TRIALS study record update · 2013-10-14
  A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Phase 2 Trial to Evaluate the Efficacy and Safety of Dapagliflozin as Monotherapy in Japanese Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control
• CLINICAL_TRIALS study record update · 2013-10-09
  Safety and Effect of Liraglutide in Patients With Type 2 Diabetes and Severe Renal Insufficiency
• CLINICAL_TRIALS study record update · 2013-10-08
  A Descriptive Study of the Efficacy and Safety of ONGLYZA (Saxagliptin) Under Conditions of Actual Use in the Philippines
• CLINICAL_TRIALS study record update · 2013-09-26
  The Effect of Intensive and Short-term Insulin Treatment on Long-term Pancreatic β-cell Function in Newly Diagnosed People With Type 2 Diabetes in Korea
• CLINICAL_TRIALS study record update · 2013-09-25
  A Prospective, Randomized, Multicenter Study of the Efficacy and Safety of Oral Acarbose Treatment in Patients With Type 2 Diabetes Mellitus
• CLINICAL_TRIALS study record update · 2013-09-18
  Ready to Act. A Health Education Programme for People With Screen-detected Hyperglycaemia
• CLINICAL_TRIALS study record update · 2013-09-18
  Phase 1 Study of Randomized Clinical Trial Comparing Vitamin C Supplementation Plus Oral Hypoglycemic Drugs Versus Hypoglycemic Drugs Alone on Serum Selenium, Zinc, Copper and Malondialdehyde Levels in Type 2 Diabetes Mellitus and Its Microvascular Complications
• CLINICAL_TRIALS study record update · 2013-09-16
  A Randomized, Double-blind, Placebo-controlled, Multiple Ascending Oral Dose Study to Evaulate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DSP-8658 in Type 2 Diabetic and Healthy Subjects
• CLINICAL_TRIALS study record update · 2013-09-13
  Phase II Study of Glycemic Control, Safety, Tolerability and Pharmacokinetic Parameters of TC-6987 Monotherapy in Subjects With Type 2 Diabetes Mellitus
• CLINICAL_TRIALS study record update · 2013-09-13
  A Multi-Center, Randomized, Double-Blind, Parallel-Group, Multiple-Dose Study Assessing the Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of GK1-399 in Patients With Type 2 Diabetes Mellitus
• CLINICAL_TRIALS study record update · 2013-09-09
  A Phase 1, Randomized, Double-Blind, Placebo-Controlled Parallel Group Study to Evaluate the Pharmacodynamic and Pharmacokinetic Effects of LX4211 in Subjects With Type 2 Diabetes Mellitus and Moderate to Severe Renal Impairment
• CLINICAL_TRIALS study record update · 2013-08-30
  A 24-week, Multi-center, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Efficacy and Safety of Vildagliptin 50mg Bid as an add-on Therapy to Insulin, With or Without Metformin, in Patients With Type 2 Diabetes Mellitus
• CLINICAL_TRIALS study record update · 2013-08-30
  A Single-center,Double-blind,Randomised,Placebo-controlled,Parallel-group Study to Assess the Effect of 24 Weeks of Treatment With Vildagliptin on Insulin Sensitivity and Its Underlying Mechanism in Patients With T2DM Treated With Metformin